<DOC>
	<DOCNO>NCT00671359</DOCNO>
	<brief_summary>This evaluation safety , tolerance , pharmacokinetics single oral dos TR-701 give normal , healthy , adult volunteer feed fasted state .</brief_summary>
	<brief_title>Food Effects Single Oral Dose 600mg TR-701</brief_title>
	<detailed_description>Subjects receive follow treatment crossover design : Treatment A : Three 200-mg capsule ( 600-mg dose ) TR-701 administer orally 240 mL room temperature tap water least 10-hour fast . Treatment B : Three 200-mg capsule ( 600-mg dose ) TR-701 administer orally 240 mL room temperature tap water follow high-fat meal precede least 10-hour fast . Descriptive statistic calculate PK parameter available , include Cmax , Tmax , AUC0-t , AUC0-inf . Minimum , maximum , mean , median value determine standard deviation calculate . Where data available , food effect examine test ( fed state ) reference ( fasted state ) group .</detailed_description>
	<mesh_term>Torezolid phosphate</mesh_term>
	<criteria>BMI 20 29.9 kg/m2 Females must either postmenopausal least 1 year , surgically sterile least 90 day , agree use acceptable method birth control history clinical manifestation clinically significant medical disorder history hypersensitivity allergy drug compound history stomach intestinal surgery resection history alcoholism drug addiction within 1 year pregnancy , lactation , breastfeed use tobaccocontaining nicotinecontaining product within 6 month use medication use alcoholcontaining , grapefruitcontaining , caffeinecontaining food beverage ; food beverage high level tyramine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Food effect</keyword>
</DOC>